A method of immune-detection for the measurement in plasma of complexes formed by Glucose-regulated protein94 (Grp94) with Immunoglobulins G (IgG), which operate as diagnostic and prognostic tumor markers, includes employing a capture (or primary) antibody directed against one of the two proteins of the complex, and a detection (or secondary) antibody directed against the other protein of the complex.
